Withdrawn: Effectiveness and safety of toripalimab, camrelizumab and sintilimab in a real‐world cohort of hepatitis B virus associated hepatocellular carcinoma patients

The above article from British Journal of Clinical Pharmacology, published online on July 5, 2020 in Wiley Online Library (http://wileyonlinelibrary.com) has been withdrawn by agreement among the authors and John Wiley & Sons Ltd on behalf of the British Pharmacology Society. The withdrawal has...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Br J Clin Pharmacol
Autori principali: Yuan, Guosheng, Hu, Xiaoyun, Li, Qi, Dai, Wencong, Cheng, Xiao, Ying, Pengfei, Yu, Wenxuan, Guo, Yabing, Chen, Mian, Chen, Jinzhang
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7495274/
https://ncbi.nlm.nih.gov/pubmed/32627214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14452
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi